All posts tagged
Qiagen gets FDA Approval for the First and Only Test for a Rare Type of Leukemia
Meet the CEO of this Intrepid Spanish Biotech exploring Epigenetics
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
Better and Safer Bone Marrow Transplants for Leukemia enter Phase III
“We want to be the Worldwide Leader in Microbiota”
10 Hot European Biotechs to Observe in 2017 🚀
The 10 Biggest Clinical Success Stories of 2016 in European Biotech
Investors bid on Nordic Nanovector’s Hottest Cancer Antibodies
Sanofi Jumps into the Biosimilars Market aiming for Asia
Can this new Antibody-Drug Conjugate Collaboration make it to the Top?
And the highest funding in Europe this year goes to… Antibody-Drug Conjugates!
It’s Blood Cancer Day, how is Biotech fixing it?
Labiotech UG, All Rights Reserved -
Send this to friend